Table: Ono Pharm -6-MTH group results (IFRS)

ONO PHARMACEUTICAL

29/10/2020 03:00

Oct 29 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2020        Sep 30, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              150.47              149.01           305.00    
                   (+1.0 pct)          (+3.2 pct)       (+4.3 pct)  
  Operating           52.40               41.88            87.00    
                   (+25.1 pct)         (+19.1 pct)      (+12.3 pct) 
  Pretax              53.67               43.04            88.50    
                   (+24.7 pct)         (+16.6 pct)      (+11.0 pct) 
  Net                 39.85               32.82            65.00    
                   (+21.4 pct)         (+13.8 pct)      (+8.9 pct)  
  EPS Basic         79.84 yen           64.58 yen       130.23 yen  
  EPS Diluted       79.83 yen           64.57 yen                   
  Ann Div                               45.00 yen        45.00 yen  
  -Q2 Div           22.50 yen           22.50 yen                   
  -Q4 Div                               22.50 yen        22.50 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T